Michael John Sumner | Chief Medical Officer
Inovio Pharmaceuticals

Dr. Sumner leads INOVIO’s clinical-stage pipeline of DNA medicines. Dr. Sumner previously served as CMO of Orexo AB and held numerous European- and US-based leadership roles at Novartis Pharmaceuticals, Aventis Behring, Novo Nordisk and Shire Pharmaceuticals. Dr. Sumner brings over 30 years of extensive pharmaceutical, medical and clinical experience driving numerous late-stage product approvals and supporting successful commercial products on a global basis across multiple therapeutic areas. Dr. Sumner received his medical degree from the University of London, is a member of the Royal College of Physicians, and holds a Master of Business Administration from Henley Management College, UK.